News from our innovation centres
Get up-to-date with our latest news and discover how other founders have flourished by reading our case studies.
Helio Display Materials moved into the Wood Centre for Innovation in April with a mission to revolutionise television screen performance with its new technology that makes colours more vivid while reducing power consumption.
We spoke to Dr Rhys Newman, Co-Founder and Chief Scientific Officer, about Visionary Machines and the software they are developing to create superhuman vision for machines.
OxDX Ltd has moved into R&D labs at the Trust’s Wood Centre for Innovation to commercialise a novel approach of detecting pathogens by the unique light signature they emit when made fluorescent.
Starting with migraines, Human Centric Drug Discovery is relying on human data to find a new generation of drugs to treat brain disorders.
Further government funding supports phase II R&D lab conversion at The Oxford Trust’s Wood Centre for Innovation
The Oxford Trust, the local charity encouraging the pursuit of science and enterprise, is to commence the second phase of its conversion of dedicated high spec laboratory facilities at its Wood Centre for Innovation in Headington, Oxford, following £0.2 million additional Local Growth Fund support, secured by the Oxfordshire Local Enterprise Partnership (OxLEP).
Optellum, a lung-health AI company based at our Oxford Centre for Innovation, has just announced a strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson. Through the collaboration, Optellum will use its AI-powered clinical decision support platform to increase lung cancer survival rates through early intervention and prevention.
An independent charitable trust, The Oxford Trust was set up by Sir Martin and Lady Audrey Wood 36 years ago to “encourage the pursuit of science and enterprise”. Their experience of setting up Oxford Instruments, one of the University of Oxford’s early, and some say most successful, spinouts enabled them to appreciate the challenges that face young entrepreneurs.
Imam Monawar Hussain, the High Sheriff of Oxfordshire and one of our trustees, officially opened our newly-converted class II R&D laboratories at the Wood Centre for Innovation alongside Jeremy Long, chair of the Oxfordshire Local Enterprise Partnership (OxLEP).
A dynamic new biotech started by Dr David Llewellyn and Dr Joe Illingworth, DJS Antibodies is pioneering the development of novel therapeutics to treat the world’s most critical inflammatory diseases, a class of disease that accounts for more than 50% of deaths worldwide.